Trial · NCT02640976
Poor Ovarian Stimulation Response in In Vitro Fertilization (IVF) Program
NCT02640976, Early phase 1, Completed, Cairo University
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Poor Ovarian Stimulation Response in In Vitro Fertilization (IVF) Program. Trials, record NCT02640976. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT02640976
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Poor Ovarian Stimulation Response in In Vitro Fertilization (IVF) Program
- NCT number
- NCT02640976
- Status
- Completed
- Phases
- Early phase 1
- Enrollment
- 216 participants, actual
- Lead sponsor
- Cairo University
- Conditions
- Infertility
- Interventions
- Human menopausal gonadotrophin (HMG), GnRH antagonist Cetrorelix, Human chorionic gonadotrophin (hCG)
- First posted
- 2015-12-29
- Last updated
- 2015-12-29
Source ClinicalTrials.gov
Registered outcomes4
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | number of oocytes collected | 3 weeks from of start of ICSI cycle | when at least 3 follicles will reach 17 mm in diameter, ovulation will be triggered by a single intra-muscular injection of 10,000 IU of hCG \[Choriomon® 5000 IU ampoules, IBSA institut\]. 36 hours later, oocyte retrieval will be performed and will be guided by transvaginal ultrasound. |
| Secondary | Detection of the single nucleotide polymorphisms ESR2(+1730G>A) (rs4986938), FSHR p.Thr307Ala (c.919A>G, rs6165) and FSHR p.Asn680Ser (c.2039A>G, rs6166) SNPs will be performed using the TaqMan system by real-time polymerase chain reaction (PCR) | Within 1 week | By using PCR, we will indicate the genotype in each individual and determine the probability of the poor ovarian response. |
| Other | Laboratory analysis of basal follicle stimulating hormone level for each individual will be measured by enzyme-linked immunosorbent assay (ELISA) | Done within 3 months preceeding the ICSI cycle | Based on FSH level, the dose of HMG ( Merional) will be adjusted for each individual. |
| Other | Laboratory analysis of anti-mullerian hormone level (AMH) will be measured by ELISA technique for each individual. | Done within 3 months preceeding the ICSI cycle. | Based on AMH level, the dose of HMG (Merional) will be adjusted for each individual. |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers1
The papers the trial lists on ClinicalTrials.gov.
| PMID | Listed as |
|---|---|
| 28825151 | DERIVED |
Source PubMed
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT02640976
GET https://conductscience.org/api/trials/v1/NCT02640976/registered